Home > > > > Report Detail

Global Antiparasitic Drugs Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Publisher Name :
Date: 05-Dec-2022
No. of pages: 123
Inquire Before Buying

Report Overview

Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Antiparasitic Drugs estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.

The USA market for Antiparasitic Drugs is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

The China market for Antiparasitic Drugs is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

The Europe market for Antiparasitic Drugs is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

The global key companies of Antiparasitic Drugs include Ipca Laboratories Ltd, Zydus Cadila, Merck, Pfizer, GlaxoSmithKline Plc., Cipla Ltd, Ranbaxy Laboratories, Novartis AG and Alvizia Health Care, etc. In 2021, the global top five players had a share approximately % in terms of revenue.

Report Scope

This latest report researches the industry structure, revenue and gross margin. Major players' headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Antiparasitic Drugs companies, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.

This report also includes a discussion of the major players across each regional Antiparasitic Drugs market. Further, it explains the major drivers and regional dynamics of the global Antiparasitic Drugs market and current trends within the industry.

Key Companies Covered

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

- Ipca Laboratories Ltd

- Zydus Cadila

- Merck

- Pfizer

- GlaxoSmithKline Plc.

- Cipla Ltd

- Ranbaxy Laboratories

- Novartis AG

- Alvizia Health Care

- Bayer AG

- Roche Inc

- Arbor Pharmaceuticals Inc.

- Sanofi

- AstraZeneca

- Alkem Laboratories Limited

Market Segments

This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.

Antiparasitic Drugs Segment by Type

- by Type

- - Anthelmintics

- - Antiprotozoals

- - Others

- by Delivery Type

- - Oral

- - Injectable

- - Topical

Antiparasitic Drugs Segment by Application

- Hospital

- Clinic

- Others

Key Regions & Countries

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Antiparasitic Drugs market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Report Includes:

This report presents an overview of global market for Antiparasitic Drugs market size. Analyses of the global market trends, with historic market revenue data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.

This report researches the key producers of Antiparasitic Drugs, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Antiparasitic Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Antiparasitic Drugs revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Antiparasitic Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Antiparasitic Drugs revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Ipca Laboratories Ltd, Zydus Cadila, Merck, Pfizer, GlaxoSmithKline Plc., Cipla Ltd, Ranbaxy Laboratories, Novartis AG and Alvizia Health Care, etc.

Global Antiparasitic Drugs Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antiparasitic Drugs Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Anthelmintics
1.2.3 Antiprotozoals
1.2.4 Others
1.3 Market by Application
1.3.1 Global Antiparasitic Drugs Market Growth Rate by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Antiparasitic Drugs Market Size (2017-2028)
2.2 Antiparasitic Drugs Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.3 Global Antiparasitic Drugs Market Size by Region (2017-2022)
2.4 Global Antiparasitic Drugs Market Size Forecast by Region (2023-2028)
2.5 Global Top Antiparasitic Drugs Countries Ranking by Market Size
3 Antiparasitic Drugs Competitive by Company
3.1 Global Antiparasitic Drugs Revenue by Players
3.1.1 Global Antiparasitic Drugs Revenue by Players (2017-2022)
3.1.2 Global Antiparasitic Drugs Market Share by Players (2017-2022)
3.2 Global Antiparasitic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Antiparasitic Drugs Revenue
3.4 Global Antiparasitic Drugs Market Concentration Ratio
3.4.1 Global Antiparasitic Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antiparasitic Drugs Revenue in 2021
3.5 Global Antiparasitic Drugs Key Players Head office and Area Served
3.6 Key Players Antiparasitic Drugs Product Solution and Service
3.7 Date of Enter into Antiparasitic Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Antiparasitic Drugs Breakdown Data by Type
4.1 Global Antiparasitic Drugs Historic Revenue by Type (2017-2022)
4.2 Global Antiparasitic Drugs Forecasted Revenue by Type (2023-2028)
5 Global Antiparasitic Drugs Breakdown Data by Application
5.1 Global Antiparasitic Drugs Historic Market Size by Application (2017-2022)
5.2 Global Antiparasitic Drugs Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Antiparasitic Drugs Revenue by Company (2020-2022)
6.2 North America Antiparasitic Drugs Revenue by Type (2017-2028)
6.3 North America Antiparasitic Drugs Revenue by Application (2017-2028)
6.4 North America Antiparasitic Drugs Revenue by Country (2017-2028)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe Antiparasitic Drugs Revenue by Company (2020-2022)
7.2 Europe Antiparasitic Drugs Revenue by Type (2017-2028)
7.3 Europe Antiparasitic Drugs Revenue by Application (2017-2028)
7.4 Europe Antiparasitic Drugs Revenue by Country (2017-2028)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Antiparasitic Drugs Revenue by Company (2020-2022)
8.2 Asia Pacific Antiparasitic Drugs Revenue by Type (2017-2028)
8.3 Asia Pacific Antiparasitic Drugs Revenue by Application (2017-2028)
8.4 Asia Pacific Antiparasitic Drugs Revenue by Region (2017-2028)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Vietnam
9 Latin America
9.1 Latin America Antiparasitic Drugs Revenue by Company (2020-2022)
9.2 Latin America Antiparasitic Drugs Revenue by Type (2017-2028)
9.3 Latin America Antiparasitic Drugs Revenue by Application (2017-2028)
9.4 Latin America Antiparasitic Drugs Revenue by Country (2017-2028)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Antiparasitic Drugs Revenue by Company (2020-2022)
10.2 Middle East and Africa Antiparasitic Drugs Revenue by Type (2017-2028)
10.3 Middle East and Africa Antiparasitic Drugs Revenue by Application (2017-2028)
10.4 Middle East and Africa Antiparasitic Drugs Revenue by Country (2017-2028)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11 Company Profiles
11.1 Ipca Laboratories Ltd
11.1.1 Ipca Laboratories Ltd Company Details
11.1.2 Ipca Laboratories Ltd Business Overview
11.1.3 Ipca Laboratories Ltd Antiparasitic Drugs Products and Services
11.1.4 Ipca Laboratories Ltd Antiparasitic Drugs Revenue in Antiparasitic Drugs Business (2017-2022)
11.1.5 Ipca Laboratories Ltd Antiparasitic Drugs SWOT Analysis
11.1.6 Ipca Laboratories Ltd Recent Developments
11.2 Zydus Cadila
11.2.1 Zydus Cadila Company Details
11.2.2 Zydus Cadila Business Overview
11.2.3 Zydus Cadila Antiparasitic Drugs Products and Services
11.2.4 Zydus Cadila Antiparasitic Drugs Revenue in Antiparasitic Drugs Business (2017-2022)
11.2.5 Zydus Cadila Antiparasitic Drugs SWOT Analysis
11.2.6 Zydus Cadila Recent Developments
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Merck Business Overview
11.3.3 Merck Antiparasitic Drugs Products and Services
11.3.4 Merck Antiparasitic Drugs Revenue in Antiparasitic Drugs Business (2017-2022)
11.3.5 Merck Antiparasitic Drugs SWOT Analysis
11.3.6 Merck Recent Developments
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Antiparasitic Drugs Products and Services
11.4.4 Pfizer Antiparasitic Drugs Revenue in Antiparasitic Drugs Business (2017-2022)
11.4.5 Pfizer Antiparasitic Drugs SWOT Analysis
11.4.6 Pfizer Recent Developments
11.5 GlaxoSmithKline Plc.
11.5.1 GlaxoSmithKline Plc. Company Details
11.5.2 GlaxoSmithKline Plc. Business Overview
11.5.3 GlaxoSmithKline Plc. Antiparasitic Drugs Products and Services
11.5.4 GlaxoSmithKline Plc. Antiparasitic Drugs Revenue in Antiparasitic Drugs Business (2017-2022)
11.5.5 GlaxoSmithKline Plc. Antiparasitic Drugs SWOT Analysis
11.5.6 GlaxoSmithKline Plc. Recent Developments
11.6 Cipla Ltd
11.6.1 Cipla Ltd Company Details
11.6.2 Cipla Ltd Business Overview
11.6.3 Cipla Ltd Antiparasitic Drugs Products and Services
11.6.4 Cipla Ltd Antiparasitic Drugs Revenue in Antiparasitic Drugs Business (2017-2022)
11.6.5 Cipla Ltd Antiparasitic Drugs SWOT Analysis
11.6.6 Cipla Ltd Recent Developments
11.7 Ranbaxy Laboratories
11.7.1 Ranbaxy Laboratories Company Details
11.7.2 Ranbaxy Laboratories Business Overview
11.7.3 Ranbaxy Laboratories Antiparasitic Drugs Products and Services
11.7.4 Ranbaxy Laboratories Antiparasitic Drugs Revenue in Antiparasitic Drugs Business (2017-2022)
11.7.5 Ranbaxy Laboratories Antiparasitic Drugs SWOT Analysis
11.7.6 Ranbaxy Laboratories Recent Developments
11.8 Novartis AG
11.8.1 Novartis AG Company Details
11.8.2 Novartis AG Business Overview
11.8.3 Novartis AG Antiparasitic Drugs Products and Services
11.8.4 Novartis AG Antiparasitic Drugs Revenue in Antiparasitic Drugs Business (2017-2022)
11.8.5 Novartis AG Antiparasitic Drugs SWOT Analysis
11.8.6 Novartis AG Recent Developments
11.9 Alvizia Health Care
11.9.1 Alvizia Health Care Company Details
11.9.2 Alvizia Health Care Business Overview
11.9.3 Alvizia Health Care Antiparasitic Drugs Products and Services
11.9.4 Alvizia Health Care Antiparasitic Drugs Revenue in Antiparasitic Drugs Business (2017-2022)
11.9.5 Alvizia Health Care Antiparasitic Drugs SWOT Analysis
11.9.6 Alvizia Health Care Recent Developments
11.10 Bayer AG
11.10.1 Bayer AG Company Details
11.10.2 Bayer AG Business Overview
11.10.3 Bayer AG Antiparasitic Drugs Products and Services
11.10.4 Bayer AG Antiparasitic Drugs Revenue in Antiparasitic Drugs Business (2017-2022)
11.10.5 Bayer AG Antiparasitic Drugs SWOT Analysis
11.10.6 Bayer AG Recent Developments
11.11 Roche Inc
11.11.1 Roche Inc Company Details
11.11.2 Roche Inc Business Overview
11.11.3 Roche Inc Antiparasitic Drugs Products and Services
11.11.4 Roche Inc Antiparasitic Drugs Revenue in Antiparasitic Drugs Business (2017-2022)
11.11.5 Roche Inc Recent Developments
11.12 Arbor Pharmaceuticals Inc.
11.12.1 Arbor Pharmaceuticals Inc. Company Details
11.12.2 Arbor Pharmaceuticals Inc. Business Overview
11.12.3 Arbor Pharmaceuticals Inc. Antiparasitic Drugs Products and Services
11.12.4 Arbor Pharmaceuticals Inc. Antiparasitic Drugs Revenue in Antiparasitic Drugs Business (2017-2022)
11.12.5 Arbor Pharmaceuticals Inc. Recent Developments
11.13 Sanofi
11.13.1 Sanofi Company Details
11.13.2 Sanofi Business Overview
11.13.3 Sanofi Antiparasitic Drugs Products and Services
11.13.4 Sanofi Antiparasitic Drugs Revenue in Antiparasitic Drugs Business (2017-2022)
11.13.5 Sanofi Recent Developments
11.14 AstraZeneca
11.14.1 AstraZeneca Company Details
11.14.2 AstraZeneca Business Overview
11.14.3 AstraZeneca Antiparasitic Drugs Products and Services
11.14.4 AstraZeneca Antiparasitic Drugs Revenue in Antiparasitic Drugs Business (2017-2022)
11.14.5 AstraZeneca Recent Developments
11.15 Alkem Laboratories Limited
11.15.1 Alkem Laboratories Limited Company Details
11.15.2 Alkem Laboratories Limited Business Overview
11.15.3 Alkem Laboratories Limited Antiparasitic Drugs Products and Services
11.15.4 Alkem Laboratories Limited Antiparasitic Drugs Revenue in Antiparasitic Drugs Business (2017-2022)
11.15.5 Alkem Laboratories Limited Recent Developments
12 Antiparasitic Drugs Market Dynamics
12.1 Antiparasitic Drugs Market Trends
12.2 Antiparasitic Drugs Market Drivers
12.3 Antiparasitic Drugs Market Challenges
12.4 Antiparasitic Drugs Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
List of Tables
Table 1. Global Antiparasitic Drugs Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Anthelmintics
Table 3. Key Players of Antiprotozoals
Table 4. Key Players of Others
Table 5. Global Antiparasitic Drugs Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 6. Global Antiparasitic Drugs Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 7. Global Antiparasitic Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 8. Global Antiparasitic Drugs Revenue Market Share by Region (2017-2022)
Table 9. Global Antiparasitic Drugs Revenue by Players (2017-2022) & (US$ Million)
Table 10. Global Antiparasitic Drugs Market Share by Players (2017-2022)
Table 11. Global Top Antiparasitic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiparasitic Drugs as of 2021)
Table 12. Ranking of Global Top Antiparasitic Drugs Companies by Revenue (US$ Million) in 2021
Table 13. Global 5 Largest Players Market Share by Antiparasitic Drugs Revenue (CR5 and HHI) & (2017-2022)
Table 14. Key Players Headquarters and Area Served
Table 15. Key Players Antiparasitic Drugs Product Solution and Service
Table 16. Date of Key Manufacturers Enter into Antiparasitic Drugs Market
Table 17. Mergers & Acquisitions, Expansion Plans
Table 18. Global Antiparasitic Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 19. Global Antiparasitic Drugs Revenue Market Share by Type (2017-2022)
Table 20. Global Antiparasitic Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 21. Global Antiparasitic Drugs Revenue Market Share by Type (2023-2028)
Table 22. Global Antiparasitic Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 23. Global Antiparasitic Drugs Revenue Market Share by Application (2017-2022)
Table 24. Global Antiparasitic Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 25. Global Antiparasitic Drugs Revenue Market Share by Application (2023-2028)
Table 26. North America Antiparasitic Drugs Revenue by Company (2020-2022) & (US$ Million)
Table 27. North America Antiparasitic Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 28. North America Antiparasitic Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 29. North America Antiparasitic Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 30. North America Antiparasitic Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 31. North America Antiparasitic Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 32. North America Antiparasitic Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 33. Europe Antiparasitic Drugs Revenue by Company (2020-2022) & (US$ Million)
Table 34. Europe Antiparasitic Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 35. Europe Antiparasitic Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 36. Europe Antiparasitic Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 37. Europe Antiparasitic Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 38. Europe Antiparasitic Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 39. Europe Antiparasitic Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 40. Asia Pacific Antiparasitic Drugs Revenue by Company (2020-2022) & (US$ Million)
Table 41. Asia Pacific Antiparasitic Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 42. Asia Pacific Antiparasitic Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 43. Asia Pacific Antiparasitic Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 44. Asia Pacific Antiparasitic Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 45. Asia Pacific Antiparasitic Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 46. Asia Pacific Antiparasitic Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 47. Latin America Antiparasitic Drugs Revenue by Company (2020-2022) & (US$ Million)
Table 48. Latin America Antiparasitic Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 49. Latin America Antiparasitic Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 50. Latin America Antiparasitic Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 51. Latin America Antiparasitic Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 52. Latin America Antiparasitic Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 53. Latin America Antiparasitic Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 54. Middle East and Africa Antiparasitic Drugs Revenue by Company (2020-2022) & (US$ Million)
Table 55. Middle East and Africa Antiparasitic Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa Antiparasitic Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Antiparasitic Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Antiparasitic Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Antiparasitic Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Antiparasitic Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 61. Ipca Laboratories Ltd Company Details
Table 62. Ipca Laboratories Ltd Business Overview
Table 63. Ipca Laboratories Ltd Antiparasitic Drugs Product and Services
Table 64. Ipca Laboratories Ltd Antiparasitic Drugs Revenue in Antiparasitic Drugs Business (2017-2022) & (US$ Million)
Table 65. Ipca Laboratories Ltd Antiparasitic Drugs SWOT Analysis
Table 66. Ipca Laboratories Ltd Recent Developments
Table 67. Zydus Cadila Company Details
Table 68. Zydus Cadila Business Overview
Table 69. Zydus Cadila Antiparasitic Drugs Product and Services
Table 70. Zydus Cadila Antiparasitic Drugs Revenue in Antiparasitic Drugs Business (2017-2022) & (US$ Million)
Table 71. Zydus Cadila Antiparasitic Drugs SWOT Analysis
Table 72. Zydus Cadila Recent Developments
Table 73. Merck Company Details
Table 74. Merck Business Overview
Table 75. Merck Antiparasitic Drugs Product and Services
Table 76. Merck Antiparasitic Drugs Revenue in Antiparasitic Drugs Business (2017-2022) & (US$ Million)
Table 77. Merck Antiparasitic Drugs SWOT Analysis
Table 78. Merck Recent Developments
Table 79. Pfizer Company Details
Table 80. Pfizer Business Overview
Table 81. Pfizer Antiparasitic Drugs Product and Services
Table 82. Pfizer Antiparasitic Drugs Revenue in Antiparasitic Drugs Business (2017-2022) & (US$ Million)
Table 83. Pfizer Antiparasitic Drugs SWOT Analysis
Table 84. Pfizer Recent Developments
Table 85. GlaxoSmithKline Plc. Company Details
Table 86. GlaxoSmithKline Plc. Business Overview
Table 87. GlaxoSmithKline Plc. Antiparasitic Drugs Product and Services
Table 88. GlaxoSmithKline Plc. Antiparasitic Drugs Revenue in Antiparasitic Drugs Business (2017-2022) & (US$ Million)
Table 89. GlaxoSmithKline Plc. Antiparasitic Drugs SWOT Analysis
Table 90. GlaxoSmithKline Plc. Recent Developments
Table 91. Cipla Ltd Company Details
Table 92. Cipla Ltd Business Overview
Table 93. Cipla Ltd Antiparasitic Drugs Product and Services
Table 94. Cipla Ltd Antiparasitic Drugs Revenue in Antiparasitic Drugs Business (2017-2022) & (US$ Million)
Table 95. Cipla Ltd Antiparasitic Drugs SWOT Analysis
Table 96. Cipla Ltd Recent Developments
Table 97. Ranbaxy Laboratories Company Details
Table 98. Ranbaxy Laboratories Business Overview
Table 99. Ranbaxy Laboratories Antiparasitic Drugs Product and Services
Table 100. Ranbaxy Laboratories Antiparasitic Drugs Revenue in Antiparasitic Drugs Business (2017-2022) & (US$ Million)
Table 101. Ranbaxy Laboratories Antiparasitic Drugs SWOT Analysis
Table 102. Ranbaxy Laboratories Recent Developments
Table 103. Novartis AG Company Details
Table 104. Novartis AG Business Overview
Table 105. Novartis AG Antiparasitic Drugs Product and Services
Table 106. Novartis AG Antiparasitic Drugs Revenue in Antiparasitic Drugs Business (2017-2022) & (US$ Million)
Table 107. Novartis AG Antiparasitic Drugs SWOT Analysis
Table 108. Novartis AG Recent Developments
Table 109. Alvizia Health Care Company Details
Table 110. Alvizia Health Care Business Overview
Table 111. Alvizia Health Care Antiparasitic Drugs Product and Services
Table 112. Alvizia Health Care Antiparasitic Drugs Revenue in Antiparasitic Drugs Business (2017-2022) & (US$ Million)
Table 113. Alvizia Health Care Antiparasitic Drugs SWOT Analysis
Table 114. Alvizia Health Care Recent Developments
Table 115. Bayer AG Company Details
Table 116. Bayer AG Business Overview
Table 117. Bayer AG Antiparasitic Drugs Product and Services
Table 118. Bayer AG Antiparasitic Drugs Revenue in Antiparasitic Drugs Business (2017-2022) & (US$ Million)
Table 119. Bayer AG Antiparasitic Drugs SWOT Analysis
Table 120. Bayer AG Recent Developments
Table 121. Roche Inc Company Details
Table 122. Roche Inc Business Overview
Table 123. Roche Inc Antiparasitic Drugs Product and Services
Table 124. Roche Inc Antiparasitic Drugs Revenue in Antiparasitic Drugs Business (2017-2022) & (US$ Million)
Table 125. Roche Inc Recent Developments
Table 126. Arbor Pharmaceuticals Inc. Company Details
Table 127. Arbor Pharmaceuticals Inc. Business Overview
Table 128. Arbor Pharmaceuticals Inc. Antiparasitic Drugs Product and Services
Table 129. Arbor Pharmaceuticals Inc. Antiparasitic Drugs Revenue in Antiparasitic Drugs Business (2017-2022) & (US$ Million)
Table 130. Arbor Pharmaceuticals Inc. Recent Developments
Table 131. Sanofi Company Details
Table 132. Sanofi Business Overview
Table 133. Sanofi Antiparasitic Drugs Product and Services
Table 134. Sanofi Antiparasitic Drugs Revenue in Antiparasitic Drugs Business (2017-2022) & (US$ Million)
Table 135. Sanofi Recent Developments
Table 136. AstraZeneca Company Details
Table 137. AstraZeneca Business Overview
Table 138. AstraZeneca Antiparasitic Drugs Product and Services
Table 139. AstraZeneca Antiparasitic Drugs Revenue in Antiparasitic Drugs Business (2017-2022) & (US$ Million)
Table 140. AstraZeneca Recent Developments
Table 141. Alkem Laboratories Limited Company Details
Table 142. Alkem Laboratories Limited Business Overview
Table 143. Alkem Laboratories Limited Antiparasitic Drugs Product and Services
Table 144. Alkem Laboratories Limited Antiparasitic Drugs Revenue in Antiparasitic Drugs Business (2017-2022) & (US$ Million)
Table 145. Alkem Laboratories Limited Recent Developments
Table 146. Antiparasitic Drugs Market Trends
Table 147. Antiparasitic Drugs Market Drivers
Table 148. Antiparasitic Drugs Market Challenges
Table 149. Antiparasitic Drugs Market Restraints
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Antiparasitic Drugs Sales Market Share by Type: 2021 VS 2028
Figure 2. Anthelmintics Features
Figure 3. Antiprotozoals Features
Figure 4. Others Features
Figure 5. Global Antiparasitic Drugs Sales Market Share by Application: 2021 VS 2028
Figure 6. Hospital Case Studies
Figure 7. Clinic Case Studies
Figure 8. Others Case Studies
Figure 9. Antiparasitic Drugs Report Years Considered
Figure 10. Global Antiparasitic Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Antiparasitic Drugs Market Size 2017-2028 (US$ Million)
Figure 12. Global Antiparasitic Drugs Market Size Market Share by Region: 2021 VS 2028
Figure 13. Global Antiparasitic Drugs Revenue Market Share by Region in 2017 VS 2022
Figure 14. Global Top 10 Antiparasitic Drugs Countries Ranking by Market Size (US$ Million) in 2021
Figure 15. Global Antiparasitic Drugs Market Share by Players in 2021
Figure 16. Global Top Antiparasitic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiparasitic Drugs as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Antiparasitic Drugs Revenue in 2021
Figure 18. North America Antiparasitic Drugs Revenue Market Share by Company in 2021
Figure 19. North America Antiparasitic Drugs Revenue Market Share by Type (2017-2028)
Figure 20. North America Antiparasitic Drugs Revenue Market Share by Application (2017-2028)
Figure 21. North America Antiparasitic Drugs Revenue Share by Country (2017-2028)
Figure 22. U.S. Antiparasitic Drugs Revenue (2017-2028) & (US$ Million)
Figure 23. Canada Antiparasitic Drugs Revenue (2017-2028) & (US$ Million)
Figure 24. Europe Antiparasitic Drugs Revenue Market Share by Company in 2021
Figure 25. Europe Antiparasitic Drugs Revenue Market Share by Type (2017-2028)
Figure 26. Europe Antiparasitic Drugs Revenue Market Share by Application (2017-2028)
Figure 27. Europe Antiparasitic Drugs Revenue Share by Country (2017-2028)
Figure 28. Germany Antiparasitic Drugs Revenue (2017-2028) & (US$ Million)
Figure 29. France Antiparasitic Drugs Revenue (2017-2028) & (US$ Million)
Figure 30. U.K. Antiparasitic Drugs Revenue (2017-2028) & (US$ Million)
Figure 31. Italy Antiparasitic Drugs Revenue (2017-2028) & (US$ Million)
Figure 32. Russia Antiparasitic Drugs Revenue (2017-2028) & (US$ Million)
Figure 33. Asia Pacific Antiparasitic Drugs Revenue Market Share by Company in 2021
Figure 34. Asia Pacific Antiparasitic Drugs Revenue Market Share by Type (2017-2028)
Figure 35. Asia Pacific Antiparasitic Drugs Revenue Market Share by Application (2017-2028)
Figure 36. Asia Pacific Antiparasitic Drugs Revenue Share by Region (2017-2028)
Figure 37. China Antiparasitic Drugs Revenue (2017-2028) & (US$ Million)
Figure 38. Japan Antiparasitic Drugs Revenue (2017-2028) & (US$ Million)
Figure 39. South Korea Antiparasitic Drugs Revenue (2017-2028) & (US$ Million)
Figure 40. India Antiparasitic Drugs Revenue (2017-2028) & (US$ Million)
Figure 41. Australia Antiparasitic Drugs Revenue (2017-2028) & (US$ Million)
Figure 42. Taiwan Antiparasitic Drugs Revenue (2017-2028) & (US$ Million)
Figure 43. Indonesia Antiparasitic Drugs Revenue (2017-2028) & (US$ Million)
Figure 44. Thailand Antiparasitic Drugs Revenue (2017-2028) & (US$ Million)
Figure 45. Malaysia Antiparasitic Drugs Revenue (2017-2028) & (US$ Million)
Figure 46. Philippines Antiparasitic Drugs Revenue (2017-2028) & (US$ Million)
Figure 47. Vietnam Antiparasitic Drugs Revenue (2017-2028) & (US$ Million)
Figure 48. Latin America Antiparasitic Drugs Revenue Market Share by Company in 2021
Figure 49. Latin America Antiparasitic Drugs Revenue Market Share by Type (2017-2028)
Figure 50. Latin America Antiparasitic Drugs Revenue Market Share by Application (2017-2028)
Figure 51. Latin America Antiparasitic Drugs Revenue Share by Country (2017-2028)
Figure 52. Mexico Antiparasitic Drugs Revenue (2017-2028) & (US$ Million)
Figure 53. Brazil Antiparasitic Drugs Revenue (2017-2028) & (US$ Million)
Figure 54. Argentina Antiparasitic Drugs Revenue (2017-2028) & (US$ Million)
Figure 55. Middle East and Africa Antiparasitic Drugs Revenue Market Share by Company in 2021
Figure 56. Middle East and Africa Antiparasitic Drugs Revenue Market Share by Type (2017-2028)
Figure 57. Middle East and Africa Antiparasitic Drugs Revenue Market Share by Application (2017-2028)
Figure 58. Middle East and Africa Antiparasitic Drugs Revenue Share by Country (2017-2028)
Figure 59. Turkey Antiparasitic Drugs Revenue (2017-2028) & (US$ Million)
Figure 60. Saudi Arabia Antiparasitic Drugs Revenue (2017-2028) & (US$ Million)
Figure 61. UAE Antiparasitic Drugs Revenue (2017-2028) & (US$ Million)
Figure 62. Ipca Laboratories Ltd Revenue Growth Rate in Antiparasitic Drugs Business (2017-2022)
Figure 63. Zydus Cadila Revenue Growth Rate in Antiparasitic Drugs Business (2017-2022)
Figure 64. Merck Revenue Growth Rate in Antiparasitic Drugs Business (2017-2022)
Figure 65. Pfizer Revenue Growth Rate in Antiparasitic Drugs Business (2017-2022)
Figure 66. GlaxoSmithKline Plc. Revenue Growth Rate in Antiparasitic Drugs Business (2017-2022)
Figure 67. Cipla Ltd Revenue Growth Rate in Antiparasitic Drugs Business (2017-2022)
Figure 68. Ranbaxy Laboratories Revenue Growth Rate in Antiparasitic Drugs Business (2017-2022)
Figure 69. Novartis AG Revenue Growth Rate in Antiparasitic Drugs Business (2017-2022)
Figure 70. Alvizia Health Care Revenue Growth Rate in Antiparasitic Drugs Business (2017-2022)
Figure 71. Bayer AG Revenue Growth Rate in Antiparasitic Drugs Business (2017-2022)
Figure 72. Roche Inc Revenue Growth Rate in Antiparasitic Drugs Business (2017-2022)
Figure 73. Arbor Pharmaceuticals Inc. Revenue Growth Rate in Antiparasitic Drugs Business (2017-2022)
Figure 74. Sanofi Revenue Growth Rate in Antiparasitic Drugs Business (2017-2022)
Figure 75. AstraZeneca Revenue Growth Rate in Antiparasitic Drugs Business (2017-2022)
Figure 76. Alkem Laboratories Limited Revenue Growth Rate in Antiparasitic Drugs Business (2017-2022)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed
  • Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87
    The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......
  • Global Esomeprazole Magnesium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74
    The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......
  • Global Combination Therapy Drug Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......
  • Global Axitinib Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68
    The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......
  • Global Lyme Disease Vaccine Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70
    The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......
  • Global Transdermal Absorption Patch Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......
  • Global Ketoprofen Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......
  • Global Methyl Salicylate Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82
    The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......
  • Global Diclofenac Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs